Echo time optimization of 2HG-edited MRS and T2 determination of tumor 
metabolites at 3T

Chan, K; Rapani, R; Maher, EA; Patel, TR; Henning, A

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Meeting Abstract

Echo time optimization of 2HG-edited MRS and T2 determination of tumor metabolites at 3T

MPS-Authors

/persons/resource/persons84402

Henning, A
Research Group MR Spectroscopy and Ultra-High Field Methodology, Max Planck Institute for Biological Cybernetics, Max Planck Society;

External Resource

https://archive.ismrm.org/2024/3262.html
(Abstract)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Chan, K., Rapani, R., Maher, E., Patel, T., & Henning, A. (2024). Echo time optimization of 2HG-edited MRS and T2 determination of tumor metabolites at 3T. In ISMRM & ISMRT Annual Meeting & Exhibition 2024.

Cite as: https://hdl.handle.net/21.11116/0000-0010-41BF-E

Abstract

Motivation: 2HG is an important oncometabolite which is commonly detected using J-difference editing.
Goal(s): Here, we determined the optimal echo time for J-difference editing of 2HG at 3T.
Approach: This was done by evaluating the echo time dependence of the 2HG-edited signal using simulations and in vivo experiments. We also quantified the T2 relaxation of 2HG as well as the co-edited glutamate and glutamine signals
Results: A TE of 90 ms was found to produce the highest signal, however, a TE of 70 ms was found to provide the best separation between 2HG and Glx in poor shimming conditions.
Impact: This optimized J-difference edited sequence could improve MRS measurements of 2HG. This would take MRS one step closer towards clinical applicability which could aid in the diagnosis and treatment monitoring of glioma patients.